Cannulation-Related Pain in Dialysis Patients With Arteriovenous Fistula
AVF
The Effect of Ice Application and Kaleidoscope Application on the Management of Cannulation-Related Pain in Dialysis Patients With Arteriovenous Fistula
1 other identifier
interventional
102
1 country
1
Brief Summary
It was conducted to investigate the effect of ice application to the kaleidoscope and hoku point on the management of cannulization-related pain in patients receiving hemodialysis treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 2, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 26, 2023
CompletedFirst Submitted
Initial submission to the registry
December 27, 2023
CompletedFirst Posted
Study publicly available on registry
February 1, 2024
CompletedFebruary 1, 2024
January 1, 2024
3 months
December 27, 2023
January 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
visual pain scale (min-max:0-10 point) (1 week= during 3rd dialysis sessions)
Evaluation of pain levels (minimum=0 points, maximum: 10 points) of experimental and control groups in the 1st, 2nd and 3rd dialysis sessions The visual pain scale is minimum 0 and maximum 10 points. 0 means no pain, 10 means severe pain. 1. st dialysis session= Visual analog pain scores during cannulation were evaluated without any application. 2. nd and 3rd dialysis sessions: Ice application to the patient's hoku point was performed by the researcher for 1 min before the AVF cannulation procedure and during cannulation, and visual analog scale pain scores was filled in during cannulation. Kaleidoscope application was performed to the patient for 5 minutes before AVF cannulation procedure and during cannulation. The visual analog scale pain score was filled in during cannulation. Control Group:visual analog scale pain scores will be evaluated before, during and after AVF cannulation without any intervention after the procedure.
One week= during 3rd dialysis sessions
Secondary Outcomes (2)
The evaluation of Ice Application and kaleidoscope application
After 3rd dialysis session (after one week)
Sociodemographic and disease-related characteristics
through study completion, an average of 3rd month.
Study Arms (3)
Kaleidoscope Group
EXPERIMENTALIn order for the patients in the kaleidoscope group to recognize the device and increase their compliance during the procedure, a practice was performed using the device before the AVF cannulation procedure. Kaleidoscope application was performed during cannulation.
Ice Application Group
EXPERIMENTALIce application application was made with non-melting ice molds to the area where the index finger and thumb of the hand with fistula are joined (HOKU point).
Control Group
EXPERIMENTALIn the control group, the vital signs of the patients before AVF cannulation will be recorded. Before, during and after AVF cannulation, VAS pain scores will be evaluated after cannulation without any intervention.
Interventions
The group consists of 34 people. Pain level was measured during 3 dialysis sessions.In order for the patients in the kaleidoscope group to recognize the device and increase their compliance during the procedure, a practice was performed using the device before the AVF cannulation procedure. Kaleidoscope application was performed during cannulation.
The group consists of 34 people. Pain level was measured during 3 dialysis sessions. Before, during and after AVF cannulation, VAS pain scores will be evaluated after cannulation without any intervention.Ice application application was made with non-melting ice molds to the area where the index finger and thumb of the hand with fistula are joined (HOKU point)
The group consists of 34 people. Pain level will be measured during 3 dialysis sessions. In the control group, the vital signs of the patients before AVF cannulation will be recorded.
Eligibility Criteria
You may qualify if:
- Comfortable reception of trill and murmur sound from arteriovenous fistula,
- over the age of 18 and no communication problems,
- Having a place and time orientation,
- No dizziness,
You may not qualify if:
- Hemodialysis of the patient with arteriovenous graft and/or central venous catheter
- Pharmacological application was made to relieve pain 30 minutes before AVF cannulation,
- The patient has a COVID - 19 infection
- Having visual, auditory and intellectual disabilities,
- Having a communication problem,
- Not willing and willing to participate in the study, as well as wanting to withdraw from the study at any stage of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sülayman YAMANlead
Study Sites (1)
Amasya University İnstitute of Health Sciences
Amasya, Merkez, 05100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The patients did the pain scoring without knowing which group they were in. Patients are blinded. In order to prevent the groups from being affected by each other, a inspection curtain was placed between the dialysis machines during the applications. The data were coded as A, B and C groups and sent for statistical analysis. The outcomes assesor doing the analysis here is blinded.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Master Student
Study Record Dates
First Submitted
December 27, 2023
First Posted
February 1, 2024
Study Start
March 13, 2023
Primary Completion
June 2, 2023
Study Completion
December 26, 2023
Last Updated
February 1, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share
The results will be shared when the author is requested for meta-analysis studies.